Adenosine A2B receptor: Difference between revisions
Jump to navigation
Jump to search
m (→Further reading: task using AWB) |
imported>JCW-CleanerBot m (→Further reading: task, replaced: Neurobiology of disease → Neurobiology of Disease) |
||
| Line 16: | Line 16: | ||
==Ligands== | ==Ligands== | ||
Research into selective A<sub>2B</sub> ligands has lagged somewhat behind the development of ligands for the other three adenosine receptor subtypes, but a number of A<sub>2B</sub>-selective compounds have now been developed,<ref name="pmid12109910">{{cite journal | vauthors = Volpini R, Costanzi S, Lambertucci C, Taffi S, Vittori S, Klotz KN, Cristalli G | title = N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands | journal = Journal of Medicinal Chemistry | volume = 45 | issue = 15 | pages = 3271–9 |date=July 2002| pmid = 12109910 | doi = 10.1021/jm0109762| issn = }}</ref><ref name="pmid12369946">{{cite journal | vauthors = Volpini R, Costanzi S, Lambertucci C, Vittori S, Cristalli G | title = Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists | journal = Current Pharmaceutical Design | volume = 8 | issue = 26 | pages = 2285–98 | year = 2002 | pmid = 12369946 | doi = 10.2174/1381612023392856| url = http://www.bentham-direct.org/pages/content.php?CPD/2002/00000008/00000026/0002B.SGM | | Research into selective A<sub>2B</sub> ligands has lagged somewhat behind the development of ligands for the other three adenosine receptor subtypes, but a number of A<sub>2B</sub>-selective compounds have now been developed,<ref name="pmid12109910">{{cite journal | vauthors = Volpini R, Costanzi S, Lambertucci C, Taffi S, Vittori S, Klotz KN, Cristalli G | title = N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands | journal = Journal of Medicinal Chemistry | volume = 45 | issue = 15 | pages = 3271–9 |date=July 2002| pmid = 12109910 | doi = 10.1021/jm0109762| issn = }}</ref><ref name="pmid12369946">{{cite journal | vauthors = Volpini R, Costanzi S, Lambertucci C, Vittori S, Cristalli G | title = Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists | journal = Current Pharmaceutical Design | volume = 8 | issue = 26 | pages = 2285–98 | year = 2002 | pmid = 12369946 | doi = 10.2174/1381612023392856 | url = http://www.bentham-direct.org/pages/content.php?CPD/2002/00000008/00000026/0002B.SGM | archive-url = https://archive.is/20130414131152/http://www.bentham-direct.org/pages/content.php?CPD/2002/00000008/00000026/0002B.SGM | dead-url = yes | archive-date = 2013-04-14 | issn = }}</ref><ref name="pmid14998332">{{cite journal | vauthors = Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA | title = Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists | journal = Journal of Medicinal Chemistry | volume = 47 | issue = 6 | pages = 1434–47 |date=March 2004| pmid = 14998332 | doi = 10.1021/jm0309654 | url = | issn = }}</ref><ref name="pmid16375751">{{cite journal | vauthors = Cacciari B, Pastorin G, Bolcato C, Spalluto G, Bacilieri M, Moro S | title = A2B adenosine receptor antagonists: recent developments | journal = Mini Reviews in Medicinal Chemistry | volume = 5 | issue = 12 | pages = 1053–60 | date = December 2005 | pmid = 16375751 | doi = 10.2174/138955705774933374 | url = http://www.bentham-direct.org/pages/content.php?MRMC/2005/00000005/00000012/0001N.SGM | archive-url = https://archive.is/20130414141112/http://www.bentham-direct.org/pages/content.php?MRMC/2005/00000005/00000012/0001N.SGM | dead-url = yes | archive-date = 2013-04-14 | issn = }}</ref><ref name="pmid17168717">{{cite journal | vauthors = Baraldi PG, Romagnoli R, Preti D, Fruttarolo F, Carrion MD, Tabrizi MA | title = Ligands for A2B adenosine receptor subtype | journal = Current Medicinal Chemistry | volume = 13 | issue = 28 | pages = 3467–82 | year = 2006 | pmid = 17168717 | doi = 10.2174/092986706779010306 | url = http://www.bentham-direct.org/pages/content.php?CMC/2006/00000013/00000028/0008C.SGM | archive-url = https://archive.is/20130414075418/http://www.bentham-direct.org/pages/content.php?CMC/2006/00000013/00000028/0008C.SGM | dead-url = yes | archive-date = 2013-04-14 | issn = }}</ref><ref name="pmid16847822">{{cite journal | vauthors = Beukers MW, Meurs I, Ijzerman AP | title = Structure-affinity relationships of adenosine A2B receptor ligands | journal = Medicinal Research Reviews | volume = 26 | issue = 5 | pages = 667–98 |date=September 2006| pmid = 16847822 | doi = 10.1002/med.20069 | url = | issn = }}</ref><ref name="pmid16275090">{{cite journal | vauthors = Elzein E, Kalla R, Li X, Perry T, Parkhill E, Palle V, Varkhedkar V, Gimbel A, Zeng D, Lustig D, Leung K, Zablocki J | title = Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists | journal = Bioorganic & Medicinal Chemistry Letters | volume = 16 | issue = 2 | pages = 302–6 |date=January 2006| pmid = 16275090 | doi = 10.1016/j.bmcl.2005.10.002 | url = | issn = }}</ref><ref name="pmid16392813">{{cite journal | vauthors = Carotti A, Cadavid MI, Centeno NB, Esteve C, Loza MI, Martinez A, Nieto R, Raviña E, Sanz F, Segarra V, Sotelo E, Stefanachi A, Vidal B | title = Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor | journal = Journal of Medicinal Chemistry | volume = 49 | issue = 1 | pages = 282–99 |date=January 2006| pmid = 16392813 | doi = 10.1021/jm0506221 | url = | issn = }}</ref><ref name="pmid18077171">{{cite journal | vauthors = Tabrizi MA, Baraldi PG, Preti D, Romagnoli R, Saponaro G, Baraldi S, Moorman AR, Zaid AN, Varani K, Borea PA | title = 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists | journal = Bioorganic & Medicinal Chemistry | volume = 16 | issue = 5 | pages = 2419–30 |date=March 2008| pmid = 18077171 | doi = 10.1016/j.bmc.2007.11.058 | url = | issn = }}</ref><ref name="pmid18226909">{{cite journal | vauthors = Stefanachi A, Brea JM, Cadavid MI, Centeno NB, Esteve C, Loza MI, Martinez A, Nieto R, Raviña E, Sanz F, Segarra V, Sotelo E, Vidal B, Carotti A | title = 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor | journal = Bioorganic & Medicinal Chemistry | volume = 16 | issue = 6 | pages = 2852–69 |date=March 2008| pmid = 18226909 | doi = 10.1016/j.bmc.2008.01.002 | url = | issn = }}</ref> and research into their potential therapeutic applications is ongoing.<ref name="pmid12570760">{{cite journal | vauthors = Volpini R, Costanzi S, Vittori S, Cristalli G, Klotz KN | title = Medicinal chemistry and pharmacology of A2B adenosine receptors | journal = Current Topics in Medicinal Chemistry | volume = 3 | issue = 4 | pages = 427–43 | year = 2003 | pmid = 12570760 | doi = 10.2174/1568026033392264 | url = http://www.bentham-direct.org/pages/content.php?CTMC/2003/00000003/00000004/0007R.SGM | archive-url = https://archive.is/20130414065741/http://www.bentham-direct.org/pages/content.php?CTMC/2003/00000003/00000004/0007R.SGM | dead-url = yes | archive-date = 2013-04-14 | issn = }}</ref><ref name="pmid17874974">{{cite journal | vauthors = Gao ZG, Jacobson KA | title = Emerging adenosine receptor agonists | journal = Expert Opinion on Emerging Drugs | volume = 12 | issue = 3 | pages = 479–92 |date=September 2007| pmid = 17874974 | doi = 10.1517/14728214.12.3.479 | url = | issn = }}</ref><ref name="pmid18536750">{{cite journal | vauthors = Kolachala V, Ruble B, Vijay-Kumar M, Wang L, Mwangi S, Figler H, Figler R, Srinivasan S, Gewirtz A, Linden J, Merlin D, Sitaraman S | title = Blockade of adenosine A2B receptors ameliorates murine colitis | journal = British Journal of Pharmacology | volume = 155 | issue = 1 | pages = 127–37 |date=September 2008| pmid = 18536750 | pmc = 2440087 | doi = 10.1038/bjp.2008.227 | url = | issn = }}</ref><ref name="pmid18758473">{{cite journal | vauthors = Haskó G, Linden J, Cronstein B, Pacher P | title = Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | journal = Nature Reviews Drug Discovery | volume = 7 | issue = 9 | pages = 759–70 |date=September 2008| pmid = 18758473 | pmc = 2568887 | doi = 10.1038/nrd2638 | url = | issn = }}</ref><ref name="pmid19075778">{{cite journal | vauthors = Ham J, Rees DA | title = The adenosine a2b receptor: its role in inflammation | journal = Endocrine, Metabolic & Immune Disorders Drug Targets | volume = 8 | issue = 4 | pages = 244–54 | date = December 2008 | pmid = 19075778 | doi = 10.2174/187153008786848303 | url = http://www.bentham-direct.org/pages/content.php?EMIDDT/2008/00000008/00000004/0003V.SGM | archive-url = https://archive.is/20130414105722/http://www.bentham-direct.org/pages/content.php?EMIDDT/2008/00000008/00000004/0003V.SGM | dead-url = yes | archive-date = 2013-04-14 | issn = }}</ref><ref name="pmid19194991">{{cite journal | vauthors = Kim MO, Kim MH, Lee SH, Suh HN, Lee YJ, Lee MY, Han HJ | title = 5'-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways in mouse embryonic stem cells | journal = Journal of Cellular Physiology | volume = 219 | issue = 3 | pages = 752–9 |date=June 2009| pmid = 19194991 | doi = 10.1002/jcp.21721 | url = | issn = }}</ref> | ||
===Agonists=== | ===Agonists=== | ||
| Line 45: | Line 45: | ||
*{{cite journal | author=Stiles GL |title=Adenosine receptors. |journal=J. Biol. Chem. |volume=267 |issue= 10 |pages= 6451–4 |year= 1992 |pmid= 1551861 |doi= }} | *{{cite journal | author=Stiles GL |title=Adenosine receptors. |journal=J. Biol. Chem. |volume=267 |issue= 10 |pages= 6451–4 |year= 1992 |pmid= 1551861 |doi= }} | ||
*{{cite journal | vauthors=Pierce KD, Furlong TJ, Selbie LA, Shine J |title=Molecular cloning and expression of an adenosine A2b receptor from human brain. |journal=Biochem. Biophys. Res. Commun. |volume=187 |issue= 1 |pages= 86–93 |year= 1992 |pmid= 1325798 |doi=10.1016/S0006-291X(05)81462-7 }} | *{{cite journal | vauthors=Pierce KD, Furlong TJ, Selbie LA, Shine J |title=Molecular cloning and expression of an adenosine A2b receptor from human brain. |journal=Biochem. Biophys. Res. Commun. |volume=187 |issue= 1 |pages= 86–93 |year= 1992 |pmid= 1325798 |doi=10.1016/S0006-291X(05)81462-7 }} | ||
*{{cite journal | vauthors=Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J |title=Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. |journal=Neurobiology of | *{{cite journal | vauthors=Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J |title=Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. |journal=Neurobiology of Disease |volume=108 |pages= 173–182 |year= 2017 |pmid= 28830843 |doi= 10.1016/j.nbd.2017.08.011 |pmc=5675803}} | ||
*{{cite journal | vauthors=Jacobson MA, Johnson RG, Luneau CJ, Salvatore CA |title=Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene. |journal=Genomics |volume=27 |issue= 2 |pages= 374–6 |year= 1995 |pmid= 7558011 |doi= 10.1006/geno.1995.1061 }} | *{{cite journal | vauthors=Jacobson MA, Johnson RG, Luneau CJ, Salvatore CA |title=Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene. |journal=Genomics |volume=27 |issue= 2 |pages= 374–6 |year= 1995 |pmid= 7558011 |doi= 10.1006/geno.1995.1061 }} | ||
*{{cite journal | vauthors=Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PR |title=Localization of the adenosine A2b receptor subtype gene (ADORA2B) to chromosome 17p11.2-p12 by FISH and PCR screening of somatic cell hybrids. |journal=Genomics |volume=25 |issue= 2 |pages= 605–7 |year= 1995 |pmid= 7790006 |doi=10.1016/0888-7543(95)80074-V }} | *{{cite journal | vauthors=Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PR |title=Localization of the adenosine A2b receptor subtype gene (ADORA2B) to chromosome 17p11.2-p12 by FISH and PCR screening of somatic cell hybrids. |journal=Genomics |volume=25 |issue= 2 |pages= 605–7 |year= 1995 |pmid= 7790006 |doi=10.1016/0888-7543(95)80074-V }} | ||
| Line 67: | Line 67: | ||
==External links== | ==External links== | ||
* {{cite web | url = http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2170 | title = Adenosine Receptors: A<sub>2B</sub> | accessdate = | date = | format = | work = IUPHAR Database of Receptors and Ion Channels | publisher = International Union of Basic and Clinical Pharmacology | pages = | language | * {{cite web | url = http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2170 | title = Adenosine Receptors: A<sub>2B</sub> | accessdate = | date = | format = | work = IUPHAR Database of Receptors and Ion Channels | publisher = International Union of Basic and Clinical Pharmacology | pages = | language = | quote = }} | ||
* {{UCSC gene info|ADORA2B}} | * {{UCSC gene info|ADORA2B}} | ||
{{G protein-coupled receptors}} | {{G protein-coupled receptors}} | ||
Latest revision as of 02:59, 16 November 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
The adenosine A2B receptor, also known as ADORA2B, is a G-protein coupled adenosine receptor, and also denotes the human adenosine A2b receptor gene which encodes it.[1]
Mechanism
This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine. This protein also interacts with netrin-1, which is involved in axon elongation.
Gene
The gene is located near the Smith-Magenis syndrome region on chromosome 17.[1]
Ligands
Research into selective A2B ligands has lagged somewhat behind the development of ligands for the other three adenosine receptor subtypes, but a number of A2B-selective compounds have now been developed,[2][3][4][5][6][7][8][9][10][11] and research into their potential therapeutic applications is ongoing.[12][13][14][15][16][17]
Agonists
- BAY 60-6583
- NECA (N-ethylcarboxamidoadenosine)
- (S)-PHPNECA - high affinity and efficacy at A2B, but poor selectivity over other adenosine receptor subtypes
- LUF-5835
- LUF-5845 - partial agonist
Antagonists and inverse agonists
- Compound 38:[18] antagonist, high affinity and good subtype selectivity
- ATL-801
- CVT-6883
- MRS-1706
- MRS-1754
- OSIP-339,391
- PSB-603
- PSB-0788
- PSB-1115
References
- ↑ 1.0 1.1 "Entrez Gene: ADORA2B adenosine A2b receptor".
- ↑ Volpini R, Costanzi S, Lambertucci C, Taffi S, Vittori S, Klotz KN, Cristalli G (July 2002). "N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands". Journal of Medicinal Chemistry. 45 (15): 3271–9. doi:10.1021/jm0109762. PMID 12109910.
- ↑ Volpini R, Costanzi S, Lambertucci C, Vittori S, Cristalli G (2002). "Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists". Current Pharmaceutical Design. 8 (26): 2285–98. doi:10.2174/1381612023392856. PMID 12369946. Archived from the original on 2013-04-14.
- ↑ Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA (March 2004). "Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists". Journal of Medicinal Chemistry. 47 (6): 1434–47. doi:10.1021/jm0309654. PMID 14998332.
- ↑ Cacciari B, Pastorin G, Bolcato C, Spalluto G, Bacilieri M, Moro S (December 2005). "A2B adenosine receptor antagonists: recent developments". Mini Reviews in Medicinal Chemistry. 5 (12): 1053–60. doi:10.2174/138955705774933374. PMID 16375751. Archived from the original on 2013-04-14.
- ↑ Baraldi PG, Romagnoli R, Preti D, Fruttarolo F, Carrion MD, Tabrizi MA (2006). "Ligands for A2B adenosine receptor subtype". Current Medicinal Chemistry. 13 (28): 3467–82. doi:10.2174/092986706779010306. PMID 17168717. Archived from the original on 2013-04-14.
- ↑ Beukers MW, Meurs I, Ijzerman AP (September 2006). "Structure-affinity relationships of adenosine A2B receptor ligands". Medicinal Research Reviews. 26 (5): 667–98. doi:10.1002/med.20069. PMID 16847822.
- ↑ Elzein E, Kalla R, Li X, Perry T, Parkhill E, Palle V, Varkhedkar V, Gimbel A, Zeng D, Lustig D, Leung K, Zablocki J (January 2006). "Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists". Bioorganic & Medicinal Chemistry Letters. 16 (2): 302–6. doi:10.1016/j.bmcl.2005.10.002. PMID 16275090.
- ↑ Carotti A, Cadavid MI, Centeno NB, Esteve C, Loza MI, Martinez A, Nieto R, Raviña E, Sanz F, Segarra V, Sotelo E, Stefanachi A, Vidal B (January 2006). "Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor". Journal of Medicinal Chemistry. 49 (1): 282–99. doi:10.1021/jm0506221. PMID 16392813.
- ↑ Tabrizi MA, Baraldi PG, Preti D, Romagnoli R, Saponaro G, Baraldi S, Moorman AR, Zaid AN, Varani K, Borea PA (March 2008). "1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists". Bioorganic & Medicinal Chemistry. 16 (5): 2419–30. doi:10.1016/j.bmc.2007.11.058. PMID 18077171.
- ↑ Stefanachi A, Brea JM, Cadavid MI, Centeno NB, Esteve C, Loza MI, Martinez A, Nieto R, Raviña E, Sanz F, Segarra V, Sotelo E, Vidal B, Carotti A (March 2008). "1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor". Bioorganic & Medicinal Chemistry. 16 (6): 2852–69. doi:10.1016/j.bmc.2008.01.002. PMID 18226909.
- ↑ Volpini R, Costanzi S, Vittori S, Cristalli G, Klotz KN (2003). "Medicinal chemistry and pharmacology of A2B adenosine receptors". Current Topics in Medicinal Chemistry. 3 (4): 427–43. doi:10.2174/1568026033392264. PMID 12570760. Archived from the original on 2013-04-14.
- ↑ Gao ZG, Jacobson KA (September 2007). "Emerging adenosine receptor agonists". Expert Opinion on Emerging Drugs. 12 (3): 479–92. doi:10.1517/14728214.12.3.479. PMID 17874974.
- ↑ Kolachala V, Ruble B, Vijay-Kumar M, Wang L, Mwangi S, Figler H, Figler R, Srinivasan S, Gewirtz A, Linden J, Merlin D, Sitaraman S (September 2008). "Blockade of adenosine A2B receptors ameliorates murine colitis". British Journal of Pharmacology. 155 (1): 127–37. doi:10.1038/bjp.2008.227. PMC 2440087. PMID 18536750.
- ↑ Haskó G, Linden J, Cronstein B, Pacher P (September 2008). "Adenosine receptors: therapeutic aspects for inflammatory and immune diseases". Nature Reviews Drug Discovery. 7 (9): 759–70. doi:10.1038/nrd2638. PMC 2568887. PMID 18758473.
- ↑ Ham J, Rees DA (December 2008). "The adenosine a2b receptor: its role in inflammation". Endocrine, Metabolic & Immune Disorders Drug Targets. 8 (4): 244–54. doi:10.2174/187153008786848303. PMID 19075778. Archived from the original on 2013-04-14.
- ↑ Kim MO, Kim MH, Lee SH, Suh HN, Lee YJ, Lee MY, Han HJ (June 2009). "5'-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways in mouse embryonic stem cells". Journal of Cellular Physiology. 219 (3): 752–9. doi:10.1002/jcp.21721. PMID 19194991.
- ↑ Stefanachi A, Nicolotti O, Leonetti F, et al. (2008). "1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A(2B) adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships". Bioorganic & Medicinal Chemistry. 16 (22): 9780–9. doi:10.1016/j.bmc.2008.09.067. PMID 18938084.
Further reading
- Stiles GL (1992). "Adenosine receptors". J. Biol. Chem. 267 (10): 6451–4. PMID 1551861.
- Pierce KD, Furlong TJ, Selbie LA, Shine J (1992). "Molecular cloning and expression of an adenosine A2b receptor from human brain". Biochem. Biophys. Res. Commun. 187 (1): 86–93. doi:10.1016/S0006-291X(05)81462-7. PMID 1325798.
- Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J (2017). "Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia". Neurobiology of Disease. 108: 173–182. doi:10.1016/j.nbd.2017.08.011. PMC 5675803. PMID 28830843.
- Jacobson MA, Johnson RG, Luneau CJ, Salvatore CA (1995). "Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene". Genomics. 27 (2): 374–6. doi:10.1006/geno.1995.1061. PMID 7558011.
- Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PR (1995). "Localization of the adenosine A2b receptor subtype gene (ADORA2B) to chromosome 17p11.2-p12 by FISH and PCR screening of somatic cell hybrids". Genomics. 25 (2): 605–7. doi:10.1016/0888-7543(95)80074-V. PMID 7790006.
- Strohmeier GR, Reppert SM, Lencer WI, Madara JL (1995). "The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia". J. Biol. Chem. 270 (5): 2387–94. doi:10.1074/jbc.270.5.2387. PMID 7836474.
- Feoktistov I, Murray JJ, Biaggioni I (1994). "Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells". Mol. Pharmacol. 45 (6): 1160–7. PMID 8022409.
- Mirabet M, Herrera C, Cordero OJ, et al. (1999). "Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation". J. Cell Sci. 112 (4): 491–502. PMID 9914161.
- Feoktistov I, Goldstein AE, Biaggioni I (1999). "Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells". Mol. Pharmacol. 55 (4): 726–34. PMID 10101031.
- Corset V, Nguyen-Ba-Charvet KT, Forcet C, et al. (2000). "Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor". Nature. 407 (6805): 747–50. doi:10.1038/35037600. PMID 11048721.
- Herrera C, Casadó V, Ciruela F, et al. (2001). "Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells". Mol. Pharmacol. 59 (1): 127–34. PMID 11125033.
- Christofi FL, Zhang H, Yu JG, et al. (2001). "Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system". J. Comp. Neurol. 439 (1): 46–64. doi:10.1002/cne.1334. PMID 11579381.
- Hayallah AM, Sandoval-Ramírez J, Reith U, et al. (2002). "1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists". J. Med. Chem. 45 (7): 1500–10. doi:10.1021/jm011049y. PMID 11906291.
- Sitaraman SV, Wang L, Wong M, et al. (2002). "The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and Ezrin upon agonist stimulation". J. Biol. Chem. 277 (36): 33188–95. doi:10.1074/jbc.M202522200. PMID 12080047.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proceedings of the National Academy of Sciences of the United States of America. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I (2003). "Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors". Circ. Res. 92 (5): 485–92. doi:10.1161/01.RES.0000061572.10929.2D. PMID 12600879.
- Eltzschig HK, Ibla JC, Furuta GT, et al. (2003). "Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors". J. Exp. Med. 198 (5): 783–96. doi:10.1084/jem.20030891. PMC 2194189. PMID 12939345.
- Ryzhov S, Goldstein AE, Matafonov A, et al. (2004). "Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma". J. Immunol. 172 (12): 7726–33. doi:10.4049/jimmunol.172.12.7726. PMID 15187156.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Kolachala V, Asamoah V, Wang L, et al. (2005). "Interferon-gamma down-regulates adenosine 2b receptor-mediated signaling and short circuit current in the intestinal epithelia by inhibiting the expression of adenylate cyclase". J. Biol. Chem. 280 (6): 4048–57. doi:10.1074/jbc.M409577200. PMID 15550390.
External links
- "Adenosine Receptors: A2B". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
- Human ADORA2B genome location and ADORA2B gene details page in the UCSC Genome Browser.